Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 561, S42-S44 (2018)
doi: https://doi.org/10.1038/d41586-018-06705-6
This article is part of Nature Outlook: Brain cancer, an editorially independent supplement produced with the financial support of third parties. About this content.
Updates & Corrections
-
Correction 01 November 2018: An earlier version of this story implied that all of the 100 people in the extended-survival subset were alive 40 months later.
References
Louveau, A. et al. Nature 523, 337–341 (2015).
Batich, K. A. et al. Clin. Cancer Res. 23, 1898–1909 (2017).
Liau, L. M. et al. J. Transl. Med. 16, 142 (2018).
O’Rourke, D. M. et al. Sci. Transl. Med. 9, eaaa0984 (2017).
Brown, M. C. et al. Sci. Transl. Med. 9, eaan4220 (2017).
Desjardins, A. et al. N. Engl. J. Med. 379, 150–161 (2018).
Cloughesy, T. F. et al. Neuro. Oncol. 20, 1383–1392 (2018).